Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

I'm going by what the study reported. The DBSM reported no sae's related to B at an interim of the study. At the end of the study the principle investigator reported the 6 sae's reported ACROSS the study were NOT considered related to brilacidin.

"All Brilacidin treatment regimens were well tolerated. There were six severe adverse events (SAE) reported across the study, none of which were considered related to Brilacidin by the principal investigator".

Whether Dr Jorgensen now lives in a nicer home has yet to be mentioned.